• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

northeast primary care





Michael R is the embodiment of useless manager marching to a broken drum. Can't talk science (as a former hospital pharmacist... appalling ) but can talk the crap out of tennis. Terrible